Anti-Viral Drug Therapy Market Report – Opportunities And Strategies – Global Forecast To 2030
The Business Research Company’s Anti-Viral Drug Therapy Market Report – Opportunities And Strategies – Global Forecast To 2030
LONDON, GREATER LONDON, UK, February 4, 2021 /EINPresswire.com/ — New year, new updates! Our reports have been revised for market size, forecasts, and strategies to take on 2021 after the COVID-19 impact: https://www.thebusinessresearchcompany.com/global-market-reports
The antiviral therapy market is expected to benefit from the latest developments in drug discovery procedures such as stem cells and organ-on-chip (OOC) technologies. OOCs are micro-engineered biometric systems that simulate the activities, mechanics and physiological responses of organ systems. Drug trial processes such as target identification, validation, and screening are being executed through OOC and stem cell technologies. These technologies are considerably reducing the drug discovery costs and generating reliable predictions on drug efficiency and human safety. Another area of development is physiology-simulation modelling, in which the integrated physiology of the human organism, in both health and disease, is simulated through a computer program. Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early stages of the drug discovery process that are operational within hours, whereas traditional models take weeks to conduct simulations. The wide adoption of these technologies is expected to drive the global antiviral drugs market in the forecast period.
The antiviral drugs therapy market size was expected to grow from $46.45 billion in 2019 to $61.57 billion in 2020 at a rate of 32.5%. The growth was mainly due to the increase in number of COVID-19 cases. The global antiviral drug therapy market is expected to grow at a CAGR of 8.3% from 2021 and reach $74.38 billion in 2023. The market is then expected to reach $87.23 billion in 2025, and $130.12 billion in 2030.
Here Is A List Of Similar Reports By The Business Research Company:
Anti-Infective Drugs Market – By Type Of Product (Antibiotics, Antivirals, Antifungals And Others (Including Anthelminthic And Antiprotozoal Drugs)), And By Region, Opportunities And Strategies – Global Forecast To 2022
https://www.thebusinessresearchcompany.com/report/anti-infective-drugs-market
Viral Vectors & Plasmid DNA Market Global Report 2020-30: COVID-19 Implications And Growth
https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-market-global-report-2020-30-covid-19-implications-and-growth
COVID19 Drug Associated APIs Market Global Report 2020: COVID-19 Growth And Change
https://www.thebusinessresearchcompany.com/report/covid19-drug-associated-apis-market-global-report-2020-covid-19-growth-and-change
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
Twitter
LinkedIn
